262 related articles for article (PubMed ID: 25189695)
1. Identification of early developmental deficits in infants with prenatal heroin, methadone, and other opioid exposure.
Beckwith AM; Burke SA
Clin Pediatr (Phila); 2015 Apr; 54(4):328-35. PubMed ID: 25189695
[TBL] [Abstract][Full Text] [Related]
2. Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes.
Kaltenbach K; O'Grady KE; Heil SH; Salisbury AL; Coyle MG; Fischer G; Martin PR; Stine S; Jones HE
Drug Alcohol Depend; 2018 Apr; 185():40-49. PubMed ID: 29413437
[TBL] [Abstract][Full Text] [Related]
3. Infants of opioid-dependent mothers: neurodevelopment at six months.
McGlone L; Mactier H
Early Hum Dev; 2015 Jan; 91(1):19-21. PubMed ID: 25460252
[TBL] [Abstract][Full Text] [Related]
4. Neonatal abstinence syndrome: Historical perspective, current focus, future directions.
Jones HE; Fielder A
Prev Med; 2015 Nov; 80():12-7. PubMed ID: 26232620
[TBL] [Abstract][Full Text] [Related]
5. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants.
McQueen KA; Murphy-Oikonen J; Gerlach K; Montelpare W
Adv Neonatal Care; 2011 Aug; 11(4):282-90. PubMed ID: 22123351
[TBL] [Abstract][Full Text] [Related]
6. [Neonatal abstinence syndrome and maternal toxicological profile].
Fundarò C; Solinas A; Martino AM; Genovese O; Noia G; Conte GL; Segni G
Minerva Pediatr; 1994 Mar; 46(3):83-8. PubMed ID: 8035762
[TBL] [Abstract][Full Text] [Related]
7. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
[TBL] [Abstract][Full Text] [Related]
8. Neonatal Abstinence Syndrome Severity Index Predicts 18-Month Neurodevelopmental Outcome in Neonates Randomized to Morphine or Methadone.
Flannery T; Davis JM; Czynski AJ; Dansereau LM; Oliveira EL; Camardo SA; Lester BM
J Pediatr; 2020 Dec; 227():101-107.e1. PubMed ID: 32805259
[TBL] [Abstract][Full Text] [Related]
9. Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine.
Bier JB; Finger AS; Bier BA; Johnson TA; Coyle MG
J Perinatol; 2015 Aug; 35(8):656-9. PubMed ID: 25836317
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
Binder T; Vavrinková B
Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
[TBL] [Abstract][Full Text] [Related]
11. Prenatal drug exposure: infant and toddler outcomes.
Bandstra ES; Morrow CE; Mansoor E; Accornero VH
J Addict Dis; 2010 Apr; 29(2):245-58. PubMed ID: 20407980
[TBL] [Abstract][Full Text] [Related]
12. Is neonatal abstinence syndrome related to the amount of opiate used?
Thajam D; Atkinson DE; Sibley CP; Lavender T
J Obstet Gynecol Neonatal Nurs; 2010; 39(5):503-9. PubMed ID: 20919996
[TBL] [Abstract][Full Text] [Related]
13. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
[TBL] [Abstract][Full Text] [Related]
14. Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates.
Jansson LM; Dipietro JA; Elko A; Velez M
J Matern Fetal Neonatal Med; 2007 Sep; 20(9):677-85. PubMed ID: 17701668
[TBL] [Abstract][Full Text] [Related]
15. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
Dryden C; Young D; Hepburn M; Mactier H
BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
[TBL] [Abstract][Full Text] [Related]
16. Neurobehavior of newborn infants exposed prenatally to methadone and identification of a neurobehavioral profile linked to poorer neurodevelopmental outcomes at age 24 months.
Wouldes TA; Woodward LJ
PLoS One; 2020; 15(10):e0240905. PubMed ID: 33064777
[TBL] [Abstract][Full Text] [Related]
17. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
[TBL] [Abstract][Full Text] [Related]
19. Behavior and development patterns in children born to heroin-addicted and methadone-addicted mothers.
Hayford SM; Epps RP; Dahl-Regis M
J Natl Med Assoc; 1988 Nov; 80(11):1197-200. PubMed ID: 2470912
[TBL] [Abstract][Full Text] [Related]
20. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates.
Leeman LM; Brown SA; Albright B; Skipper B; Hsi A; Rayburn WF
J Matern Fetal Neonatal Med; 2011 Jul; 24(7):955-9. PubMed ID: 21142769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
